PODCAST · health
C3 Glomerulopathy: From Early Recognition to Individualized Targeted Therapy
by Annenberg Center for Health Sciences
The emergence of novel targeted complement inhibitors has created new opportunities to improve the health outcomes for patients with C3 glomerulopathy (C3G). Andrew Bomback, MD, MPH, discusses the contemporary management of patients with C3G, highlighting the disease burden and complement pathway dysregulation. The safety and efficacy of approved targeted complement inhibitors are reviewed, including the importance of long-term monitoring and associated vaccination strategies. Dr. Bomback also shares his thoughts about providing personalized care by an interprofessional care team.
No episodes available yet.
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
The emergence of novel targeted complement inhibitors has created new opportunities to improve the health outcomes for patients with C3 glomerulopathy (C3G). Andrew Bomback, MD, MPH, discusses the contemporary management of patients with C3G, highlighting the disease burden and complement pathway dysregulation. The safety and efficacy of approved targeted complement inhibitors are reviewed, including the importance of long-term monitoring and associated vaccination strategies. Dr. Bomback also shares his thoughts about providing personalized care by an interprofessional care team.
HOSTED BY
Annenberg Center for Health Sciences
Loading similar podcasts...
Frequently Asked Questions
How many episodes does C3 Glomerulopathy: From Early Recognition to Individualized Targeted Therapy have?
C3 Glomerulopathy: From Early Recognition to Individualized Targeted Therapy currently has 0 episodes available on PodParley. New episodes are automatically indexed when they're published to the podcast feed.
What is C3 Glomerulopathy: From Early Recognition to Individualized Targeted Therapy about?
The emergence of novel targeted complement inhibitors has created new opportunities to improve the health outcomes for patients with C3 glomerulopathy (C3G). Andrew Bomback, MD, MPH, discusses the contemporary management of patients with C3G, highlighting the disease burden and complement pathway...
How often does C3 Glomerulopathy: From Early Recognition to Individualized Targeted Therapy release new episodes?
C3 Glomerulopathy: From Early Recognition to Individualized Targeted Therapy is no longer actively publishing new episodes, but the existing catalog remains available.
Where can I listen to C3 Glomerulopathy: From Early Recognition to Individualized Targeted Therapy?
You can listen to C3 Glomerulopathy: From Early Recognition to Individualized Targeted Therapy on PodParley by clicking any episode. We provide an embedded audio player for direct listening, and you can also subscribe via your preferred podcast app using the RSS feed.
Who hosts C3 Glomerulopathy: From Early Recognition to Individualized Targeted Therapy?
C3 Glomerulopathy: From Early Recognition to Individualized Targeted Therapy is created and hosted by Annenberg Center for Health Sciences.
URL copied to clipboard!